GlassScriptPhysician profile
Laurel M Jordan
NPI 1720188493
$6,837.60
in general payments reported to CMS, 2019-2025
28 companies · $5,180 in 2025
The $5,180 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $70.70 · 2021: $286 · 2022: $116 · 2023: $513 · 2024: $305 · 2025: $5,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,010 · Travel and Lodging: $1,646 · Food and Beverage: $1,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,009.60 |
| Travel and Lodging | $1,646.01 |
| Food and Beverage | $1,342.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,043.84 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $238.69 | 2019-2024 | |
| Organon LLC | $216.53 | 2021-2025 | Nexplanon |
| Abbvie INC. | $209.86 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $112.40 | 2023 | |
| Astellas Pharma US INC | $109.94 | 2023-2024 | Veozah |
| Gynesonics, INC. | $93.96 | 2021 | |
| Hologic Sales and Service, LLC | $93.41 | 2019-2025 | Myosure Tissue Removal Device, Acessa Provu System, Coolseal Generator |
| Pfizer INC. | $87.01 | 2022-2025 | |
| Minerva Surgical, INC | $79.22 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $67.17 | 2019-2024 | Gardasil, Gardasil 9 |
| Exeltis, USA INC. | $59.09 | 2021-2025 | Slynd |
| Millicent US INC | $57.96 | 2023-2024 | Intrarosa, Femring |
| Sage Therapeutics, LLC | $57.42 | 2024-2025 | Zurzuvae |
| Smith+Nephew, INC. | $52.82 | 2025 | Pico |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $28.20 | 2023 | Ultomiris |
| Innovation Technologies INC | $24.82 | 2024 | Irrisept |
| Mission Pharmacal Company | $23.55 | 2020 | |
| Dexcom, INC. | $23.48 | 2024 | Dexcom G6 Transmitter |
| Meditrina | $21.43 | 2023 | |
| Agile Therapeutics, INC. | $20.88 | 2021 | |
| Sumitomo Pharma America, INC. | $19.88 | 2023 | Myfembree |
| Exact Sciences Corporation | $19.68 | 2025 | Cologuard Collection Kit |
| Roche Diagnostics Corporation | $19.29 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.66 | 2023 | Exparel |
| Allergan, INC. | $14.84 | 2019 | |
| Currax Pharmaceuticals LLC | $14.79 | 2023 | Contrave, Onzetra Xsail |
| La Jolla Pharmaceutical Company | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.